Neuronetics Statistics
Share Statistics
Neuronetics has 65.82M
shares outstanding. The number of shares has increased by 119.4%
in one year.
| Shares Outstanding | 65.82M |
| Shares Change (YoY) | 119.4% |
| Shares Change (QoQ) | 105.23% |
| Owned by Institutions (%) | 24.95% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 9,439 |
| FTD / Avg. Volume | 0.84% |
Short Selling Information
The latest short interest is 3.66M, so 5.57% of the outstanding
shares have been sold short.
| Short Interest | 3.66M |
| Short % of Shares Out | 5.57% |
| Short % of Float | 9.89% |
| Short Ratio (days to cover) | 6.27 |
Valuation Ratios
The PE ratio is -1.17 and the forward
PE ratio is -22.17.
Neuronetics's PEG ratio is
-0.04.
| PE Ratio | -1.17 |
| Forward PE | -22.17 |
| PS Ratio | 0.68 |
| Forward PS | 1.3 |
| PB Ratio | 1.84 |
| P/FCF Ratio | -1.57 |
| PEG Ratio | -0.04 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Neuronetics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.86,
with a Debt / Equity ratio of 2.98.
| Current Ratio | 1.86 |
| Quick Ratio | 1.72 |
| Debt / Equity | 2.98 |
| Debt / EBITDA | -2.39 |
| Debt / FCF | -2.55 |
| Interest Coverage | -4.74 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $104,594.97 |
| Profits Per Employee | $-61,044.69 |
| Employee Count | 716 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 4.88 |
Taxes
| Income Tax | -14K |
| Effective Tax Rate | 0.03% |
Stock Price Statistics
The stock price has increased by 90.87% in the
last 52 weeks. The beta is 1.92, so Neuronetics's
price volatility has been higher than the market average.
| Beta | 1.92 |
| 52-Week Price Change | 90.87% |
| 50-Day Moving Average | 4.19 |
| 200-Day Moving Average | 2.4 |
| Relative Strength Index (RSI) | 41.55 |
| Average Volume (20 Days) | 1,124,633 |
Income Statement
In the last 12 months, Neuronetics had revenue of 74.89M
and earned -43.71M
in profits. Earnings per share was -1.38.
| Revenue | 74.89M |
| Gross Profit | 54.16M |
| Operating Income | -34.56M |
| Net Income | -43.71M |
| EBITDA | -34.56M |
| EBIT | -37.24M |
| Earnings Per Share (EPS) | -1.38 |
Full Income StatementBalance Sheet
The company has 18.46M in cash and 82.63M in
debt, giving a net cash position of -64.17M.
| Cash & Cash Equivalents | 18.46M |
| Total Debt | 82.63M |
| Net Cash | -64.17M |
| Retained Earnings | -419.79M |
| Total Assets | 141.99M |
| Working Capital | 35.83M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -31M
and capital expenditures -1.47M, giving a free cash flow of -32.46M.
| Operating Cash Flow | -31M |
| Capital Expenditures | -1.47M |
| Free Cash Flow | -32.46M |
| FCF Per Share | -1.02 |
Full Cash Flow StatementMargins
Gross margin is 72.32%, with operating and profit margins of -46.15% and -58.36%.
| Gross Margin | 72.32% |
| Operating Margin | -46.15% |
| Pretax Margin | -58.41% |
| Profit Margin | -58.36% |
| EBITDA Margin | -46.15% |
| EBIT Margin | -46.15% |
| FCF Margin | -43.35% |
